查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572286

Benexate 市场：按产品类型、配方、应用和最终用户划分 - 全球预测 2025-2030

Benexate Market by Product Type (Benexate Hydrochloride, Benexate Hydrochloride Betadex), Formulation (Capsules, Injectables, Tablets), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

Benexate市场价值2023年为5.4934亿美元，预计2024年将达到5.8438亿美元，复合年增长率为6.85%，预计到2030年将达到8.7382亿美元。

Benexate 是一种活性药物成分，常用于治疗消化性溃疡和相关胃肠道疾病，并在製药领域显示出巨大的成长潜力。这种化合物的需求是由于胃肠道疾病的盛行率不断增加以及全球医疗市场对有效药物的持续需求。该化合物的应用范围不仅限于溃疡，还可以治疗各种胃肠道疾病，凸显了治疗性介入的广泛最终用途。市场驱动因素包括新兴国家老年人口的增加和医疗保健支出的增加。这些因素增加了对有效胃肠道治疗的需求，并创造了潜在的扩张机会，特别是在医疗基础设施正在迅速发展的亚太和拉丁美洲。公司可以透过投资当地产能和优化分销网络来提高市场渗透率，从而利用这些机会。然而，严格的法律规范和与苯乙酯类产品相关的副作用等挑战可能会阻碍成长。克服这些挑战需要严格的临床试验和改进更安全的配方，这可以增强消费者的信心。创新可以采取开发先进的药物输送系统和联合治疗的形式，以提高疗效和患者依从性。此外，个人化医疗方法的研究可能会开闢新的途径并实现标靶治疗解决方案，特别是对于患有复杂胃肠道病理的患者。考虑到这些竞争考察，Benexate 市场的性质是竞争性的，但创新的时机已经成熟，其中包括大型製药企业和新兴生物技术公司。希望获得并维持市场占有率的公司必须注重策略伙伴关係、先进的研发工作以及灵活的监管合规方法。总体而言，Benexate 市场需要积极的策略来推动成长，并透过创新和策略市场定位来应对机会和挑战。

主要市场统计
基准年[2023] 5.4934 亿美元
预测年份 [2024] 5.8438 亿美元
预测年份 [2030] 87382万美元
复合年增长率（%） 6.85%

市场动态：揭示快速发展的 Benexate 市场的关键市场洞察

Benexate 市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率的增加推动了治疗市场对 Benexate 的需求
    • 不断增长的医疗保健支出和有利的政府政策提振 Benexate 市场
    • 配方技术的进步增强了 Benexate 的功效和应用
    • 由于医疗基础设施的改善，Benexate 在新兴市场的认知度和采用率有所提高
  • 市场限制因素
    • 医疗专业人员对 Benexate 的益处和用途缺乏认识和理解
    • 市场上替代疗法和治疗方法的可用性影响了对基于 Benexate 的解决方案的需求
  • 市场机会
    • 在 Benexate 市场开拓专门针对老化社会需求的医疗服务和产品
    • 利用资料分析和人工智慧为 Benexate 消费者创建个人化金融服务
    • Benexate 投资可再生能源计划，以满足都市区不断增长的能源需求
  • 市场问题
    • 客製化产品和服务以满足 Benexate 市场中不同文化的消费者需求
    • 在影响 Benexate 市场的全球动盪中保持强劲的供应链效率

波特的五力：驾驭 Benexate 市场的策略工具

波特的五力框架是了解 Benexate 市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解 Benexate 市场的外部影响

外部宏观环境因素在塑造 Benexate 市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 Benexate 市场的竞争状况

Benexate 市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 Benexate 市场供应商的绩效评估

FPNV 定位矩阵是评估 Benexate 市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 Benexate 市场的成功之路

Benexate 市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加正在增加治疗市场对 Benexate 的需求
      • 不断上涨的医疗费用和有利的政府政策正在推动 Benexate 市场
      • 药物製剂的技术进步增强了 Benexate 的功效和应用
      • 医疗保健基础设施的改善提高了 Benexate 在新兴市场的认知度和采用率
    • 抑制因素
      • 医疗保健专业人员对 Benexate 的益处和用途的认识和理解有限。
      • 市场上替代疗法和治疗方法的可用性将影响对基于 Benexate 的解决方案的需求
    • 机会
      • 开发适合老化社会需求的专业医疗服务和产品 Benexate Market
      • 利用资料分析和人工智慧为 Benexert 消费者打造个人化金融服务
      • 投资可再生能源计划，以满足 Benexat都市区不断增长的能源需求
    • 任务
      • Benexate Marketplace 客製化产品与服务，以满足不同文化消费者的需求
      • 随着全球颠覆影响全球经济，Benexate 市场维持强劲的供应链效率
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 Benexate 市场：依产品类型

  • 介绍
  • 盐酸苯乙酯
  • 盐酸苯乙酯倍他葡糖

第 7 章 Benexate 市场：依配方划分

  • 介绍
  • 胶囊
  • 注射
  • 锭剂

第 8 章 Benexate 市场：依应用分类

  • 介绍
  • 心臟病学
  • 胃肠病学
    • 胃炎
    • 消化性溃疡
  • 神经病学

第 9 章 Benexate 市场：依最终用户分类

  • 介绍
  • 居家医疗
  • 医院/诊所
  • 研究所

第10章 美洲Benexate市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区 Benexate 市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲Benexate市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 1. Astellas Pharma Inc.
  • 2. Chugai Pharmaceutical Co., Ltd.
  • 3. Daiichi Sankyo Co., Ltd.
  • 4. Eisai Co., Ltd.
  • 5. Kyowa Kirin Co., Ltd.
  • 6. Meiji Seika Pharma Co., Ltd.
  • 7. Mitsubishi Tanabe Pharma Corporation
  • 8. Nichi-Iko Pharmaceutical Co., Ltd.
  • 9. Nipro Corporation
  • 10. Otsuka Pharmaceutical Co., Ltd.
  • 11. Sawai Pharmaceutical Co., Ltd.
  • 12. Shionogi & Co., Ltd.
  • 13. Takeda Pharmaceutical Company Limited
  • 14. Teijin Pharma Limited
  • 15. Towa Pharmaceutical Co., Ltd.
Product Code: MRR-1A1A064C01F6

The Benexate Market was valued at USD 549.34 million in 2023, expected to reach USD 584.38 million in 2024, and is projected to grow at a CAGR of 6.85%, to USD 873.82 million by 2030.

Benexate, an active pharmaceutical ingredient often used for treating peptic ulcers and related gastrointestinal issues, showcases a significant growth potential in the pharmaceutical sector. The necessity for this compound stems from the increasing prevalence of gastrointestinal disorders and the ongoing demand for effective medications in the global healthcare market. Its application extends beyond ulcers, encompassing the treatment of various digestive conditions, thus highlighting its versatile end-use scope in therapeutic interventions. Market insights reveal that the rising geriatric population, coupled with an increase in healthcare spending in emerging economies, are key growth drivers. These factors amplify the demand for effective gastrointestinal treatments, creating potential opportunities for expansion, particularly in Asia-Pacific and Latin America, where healthcare infrastructure is rapidly evolving. Companies can capitalize on these opportunities by investing in local manufacturing capabilities and optimizing distribution networks to enhance market penetration. However, challenges such as stringent regulatory frameworks and side-effect profiles associated with benexate-based products may impede growth. Overcoming these could involve rigorous clinical testing and improved safety formulations, thus encouraging consumer trust. Innovation can take the form of developing advanced drug delivery systems or combination therapies that improve efficacy and patient compliance. Moreover, research into personalized medicine approaches could open new avenues, allowing for targeted therapy solutions, particularly for patients with complex gastrointestinal pathologies. Given these insights, the nature of the benexate market is competitive yet ripe for innovation, characterized by a blend of established pharmaceutical giants and emerging biotech firms. Companies aiming to capture and sustain market share need to focus on strategic partnerships, advanced R&D endeavors, and an agile approach to regulatory compliance. Overall, the benexate market demands a proactive strategy to navigate its opportunities and challenges, propelling growth through innovation and strategic market positioning.

KEY MARKET STATISTICS
Base Year [2023] USD 549.34 million
Estimated Year [2024] USD 584.38 million
Forecast Year [2030] USD 873.82 million
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Benexate Market

The Benexate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases driving demand for benexate in the therapeutic market
    • Rising healthcare expenditure and favorable government policies boosting the benexate market
    • Technological advancements in drug formulation enhancing the efficacy and application of benexate
    • Growing awareness and adoption of benexate in emerging markets due to improved healthcare infrastructure
  • Market Restraints
    • Limited awareness and understanding among healthcare professionals about the benefits and usage of Benexate
    • The availability of alternative therapies and treatments in the market impacts the demand for Benexate-based solutions
  • Market Opportunities
    • Developing specialized healthcare services and products targeting the needs of aging population in Benexate market
    • Creating personalized financial services leveraging data analytics and AI for Benexate consumers
    • Investing in renewable energy projects to meet the increasing energy demands of Benexate's urban areas
  • Market Challenges
    • Tailoring products and services to meet culturally diverse consumer needs in the Benexate Market
    • Maintaining robust supply chain efficiencies amidst global disruptions impacting the Benexate Market

Porter's Five Forces: A Strategic Tool for Navigating the Benexate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Benexate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Benexate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Benexate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Benexate Market

A detailed market share analysis in the Benexate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Benexate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Benexate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Benexate Market

A strategic analysis of the Benexate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Benexate Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Meiji Seika Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nichi-Iko Pharmaceutical Co., Ltd., Nipro Corporation, Otsuka Pharmaceutical Co., Ltd., Sawai Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, and Towa Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Benexate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Benexate Hydrochloride and Benexate Hydrochloride Betadex.
  • Based on Formulation, market is studied across Capsules, Injectables, and Tablets.
  • Based on Application, market is studied across Cardiology, Gastroenterology, and Neurology. The Gastroenterology is further studied across Gastritis and Peptic Ulcers.
  • Based on End-User, market is studied across Homecare Settings, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases driving demand for benexate in the therapeutic market
      • 5.1.1.2. Rising healthcare expenditure and favorable government policies boosting the benexate market
      • 5.1.1.3. Technological advancements in drug formulation enhancing the efficacy and application of benexate
      • 5.1.1.4. Growing awareness and adoption of benexate in emerging markets due to improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and understanding among healthcare professionals about the benefits and usage of Benexate
      • 5.1.2.2. The availability of alternative therapies and treatments in the market impacts the demand for Benexate-based solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing specialized healthcare services and products targeting the needs of aging population in Benexate market
      • 5.1.3.2. Creating personalized financial services leveraging data analytics and AI for Benexate consumers
      • 5.1.3.3. Investing in renewable energy projects to meet the increasing energy demands of Benexate's urban areas
    • 5.1.4. Challenges
      • 5.1.4.1. Tailoring products and services to meet culturally diverse consumer needs in the Benexate Market
      • 5.1.4.2. Maintaining robust supply chain efficiencies amidst global disruptions impacting the Benexate Market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Benexate Market, by Product Type

  • 6.1. Introduction
  • 6.2. Benexate Hydrochloride
  • 6.3. Benexate Hydrochloride Betadex

7. Benexate Market, by Formulation

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Injectables
  • 7.4. Tablets

8. Benexate Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Gastroenterology
    • 8.3.1. Gastritis
    • 8.3.2. Peptic Ulcers
  • 8.4. Neurology

9. Benexate Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare Settings
  • 9.3. Hospitals & Clinics
  • 9.4. Research Institutes

10. Americas Benexate Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Benexate Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Benexate Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Chugai Pharmaceutical Co., Ltd.
  • 3. Daiichi Sankyo Co., Ltd.
  • 4. Eisai Co., Ltd.
  • 5. Kyowa Kirin Co., Ltd.
  • 6. Meiji Seika Pharma Co., Ltd.
  • 7. Mitsubishi Tanabe Pharma Corporation
  • 8. Nichi-Iko Pharmaceutical Co., Ltd.
  • 9. Nipro Corporation
  • 10. Otsuka Pharmaceutical Co., Ltd.
  • 11. Sawai Pharmaceutical Co., Ltd.
  • 12. Shionogi & Co., Ltd.
  • 13. Takeda Pharmaceutical Company Limited
  • 14. Teijin Pharma Limited
  • 15. Towa Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. BENEXATE MARKET RESEARCH PROCESS
  • FIGURE 2. BENEXATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BENEXATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BENEXATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BENEXATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BENEXATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BENEXATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BENEXATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BENEXATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BENEXATE MARKET DYNAMICS
  • TABLE 7. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BENEXATE MARKET SIZE, BY BENEXATE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BENEXATE MARKET SIZE, BY BENEXATE HYDROCHLORIDE BETADEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BENEXATE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BENEXATE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BENEXATE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BENEXATE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BENEXATE MARKET SIZE, BY GASTRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BENEXATE MARKET SIZE, BY PEPTIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BENEXATE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BENEXATE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BENEXATE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BENEXATE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. BENEXATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. BENEXATE MARKET, FPNV POSITIONING MATRIX, 2023